Tuesday, November 24, 2009, 3:58AM AEST - The Australian Stockmarket opens in 6 hours and 2 minutes.
To create a watchlist or portfolio of shares, Register

Pall Corp. (PLL)

3:43AM AEST: 32.79 USD  Up 0.54 (1.67%)  
 MORE ON PLL 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 PALL CP (NYSE:PLL) Delayed quote dataEdit
Last Trade:32.79 USD
Trade Time: 3:43AM AEST
Change:Up 0.54 (1.67%)
Prev Close:32.25
Open:32.71
Bid:N/A
Ask:N/A
1y Target Est:33.83
Day's Range:32.61 - 32.99
52wk Range:18.20 - 35.23
Volume:210,267
Avg Vol (3m):888,635
Market Cap:3.83B
P/E (ttm):20.04
EPS (ttm):1.64
Div & Yield:0.58 (1.80%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add PLL to Portfolio   Download Data

 HEADLINES 
Set For Strength to Close 2009
Indie Research (Thu, Nov 19)
Pall 1Q sales hurt by shaky economy
AP (Thu, Nov 19)
UPDATE - Pall Corp sales down 5.4 percent in quarter
at Reuters (Thu, Nov 19)
Pall Corp. reports decline in quarterly sales
at MarketWatch (Thu, Nov 19)
Pall Corporation Reports First Quarter Sales
Business Wire (Thu, Nov 19)
Trading Review for Cerus Corp. Issued by Beacon Equity
GlobeNewswire (Wed, Nov 18)
Pall Corporation's New SUPRApak Filters Reduce Operating Costs for Distilleries
Business Wire (Thu, Nov 5)
Pall Scientists Selected to Present Papers on Water Desalination and Reuse at IDA World Conference
Business Wire (Thu, Nov 5)
Pall Corporation to Present at Robert W. Baird's 2009 Industrial Conference
Business Wire (Sat, Oct 31)
Thursday Options Update: AA, AVP, RDC, & PLL
at Seeking Alpha (Fri, Oct 30)
UPDATE - Entegris posts wider-than-expected Q3 loss
at Reuters (Tue, Oct 27)
More Headlines for PLL...

 ANALYST 
EPS Est (next year) (Jul-10) :1.93
EPS Est (in 2 years) (Jul-11) :2.26
Avg Rec (current)*:3.0
PEG Ratio:1.67
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Pall Corporation manufactures and markets filtration, purification, and separation products and integrated systems solutions worldwide. The company’s Life Sciences segment offers technologies that facilitate the process of drug discovery, dev...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices